Japanese pharma Shionogi has struck a deal to acquire San Diego-based Qpex Biopharma for a potential $140 million, bringing the privately-held company’s novel antimicrobial xeroborbactum into Shionogi’s development pipeline, the companies announced Monday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,